News

Categories
Please reload

Sign up
Featured Posts

How Israeli technology saved 78-year-old Leah from skin cancer

February 16, 2020

1/9
Please reload

Archive
Please reload

Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

June 4, 2020

Tel Aviv, Israel, June 4, 2020 - Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased to announce the closing of a Series B equity financing of $26 million. Investors in the round included a mix of existing investors fr...

June 3, 2020

Introduction 

When 78-year-old Israeli cancer patient Lela Parnes stumbled upon the Alpha DaRT treatment in 2017, with information from a friend of hers, she had just received her third diagnosis of cancer in multiple organs, as part of a long journey that had started i...

December 1, 2019

Dear Colleagues and Friends,

Our fourth Alpha Tau Newsletter is full of fantastic updates that I am very excited to share with you.
 
I am thrilled to inform you that our first clinical trial results have been published! The exceptional results were presented in the I...

November 26, 2019

Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors.


Tel Aviv, Israel, November 26, 2019 – Alpha Tau Medical is pleased to announce the publication of the results of its first clinical trial of Alpha DaRT™, a...

October 7, 2019

October 7 is the birth date of Danish physicist Niels Bohr [1] (1885-1862). Bohr has a special significance for Alpha Tau, for two reasons. The first reason is because he was one of the key contributors to the foundational discoveries in atomic physics at the beginning...